ArticlePloS one2013

Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer.

Eliot T McKinley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.